FDA's elevated meeting status signals transition from biomarker data discussions to Accelerated Approval discussionsOS Therapies on track to complete clinical data submission by the end of Q1 2026New ...

The treatment landscape for clear cell renal cell carcinoma (ccRCC) could be due for a shake-up following dual breakthroughs ...

Therapies backed only by lower-tier evidence no better than unmatched treatment ...

The Lincoln Partnership for Economic Development (LPED) is thrilled to announce the recipients of this year's LaunchLNK Grant Program, awarding $20,000 non-dilutive grants to six high-growth startups ...

Delivered first clinical validation of the Recursion full stack AI Operating System in FAP, demonstrating translation from AI-driven biological insight to meaningful patient outcomes; multiple clinica ...

BioNTech and partner DualityBio are accelerating the development of their B7-H3 antibody-drug conjugate into a phase 3 trial for metastatic castration-resistant prostate cancer (mCRPC). | BioNTech and ...

No one gets a call from their boss asking them to fill in for a huge name who famously quit the night before a broadcast, and ...

New Orleans Entrepreneur Week (NOEW) — the Gulf South’s premier celebration of entrepreneurship, innovation and business ...

On Sunday, February 22, restaurants and bars nationwide will be celebrating National Margarita Day with some seriously spicy discounts.

Neoadjuvant pembrolizumab (3 doses) in stage I–III disease yielded a 71% pCR rate and only one melanoma-specific survival event at 3 years post-resection. Experts discuss the SWOG S1512 trial of ...